Skip to content
NHLS WCA Number: 990000306648
  • Login to:
    • Thusano Portal
    • Proficiency Testing
    • Lab Results
    • WEB PTS Registration
    • CDW MicroStrategy
    • CSA
  • Staff Email
  • Contact Us
National Health Laboratory Service Logo National Health Laboratory Service Logo
  • Home
  • About Us
    • Overview
    • Board of Directors
    • Executive Management
    • Area Managers
    • Institutes & Subsidiaries
    • Laboratories
    • NHLS Achievements
    • Terms of Use
  • Our Services
    • Diagnostic
      • Type Of Tests
      • Diagnostic Media Products
      • Paternity Testing
      • MIC Testing
    • Academic Affairs and Research
      • Scope of Research
      • NHLS Research Trust
    • Training
    • Quality Assurance
      • Health Technology Assessment Unit
        • 2012-2021
        • 2022
        • 2023
        • 2024
        • 2025
      • Proficiency Testing
  • Priority Programmes
    • CD4
    • HIV Genotyping
    • HIV Viral Load
    • TB GeneXpert
    • Early Infant Diagnosis
  • Supply Chain
    • Latest RFQs
    • Latest Tender
    • Received Bids
    • Awarded Bids
    • Bid Cancellations
    • Bid Withdrawal
    • Awarded RFQ’s
    • RFQ Withdrawal
    • RFQ Cancellations
    • Archive
  • Key Documents
    • Annual Reports
    • Strategic Documents
    • paia
    • Acts and Bills
  • Media
    • Media Statements
    • NHLS in the News
    • Videos
    • Contact Us
  • Careers
    • Vacancies

Media Statements

  1. Home
  2. Media
  3. Media Statements
Media Statementsnhlsadmin2025-02-03T22:23:37+02:00
Mashilo Masekoa2025-10-01T15:43:16+02:00

PathReD 2025: Bridging the Diagnostic Gap, Powering Health Equity

Mashilo Masekoa2025-10-01T15:43:16+02:00October 1st, 2025|

The Pathology Research and Development Congress (PathReD) 2025, South Africa’s premier conference on pathology and diagnostics, will take place at Emperors Palace in Kempton Park, Ekurhuleni, from 2–5 October 2025. More than a scientific meeting, [...]

Mashilo Masekoa2025-09-23T14:13:14+02:00

South African Vaccine Producers Return To Antivenom Production

Mashilo Masekoa2025-09-23T14:13:14+02:00September 23rd, 2025|

Johannesburg – The National Health Laboratory Service (NHLS), through its South African Vaccine Producers (SAVP) subsidiary, announces the successful resumption of antivenom production at its newly renovated manufacturing facility. The NHLS resumed production two weeks [...]

Mashilo Masekoa2025-09-19T13:58:12+02:00

NHLS implements measures to address anatomical pathology challenges

Mashilo Masekoa2025-09-19T13:58:12+02:00September 19th, 2025|

Johannesburg — The National Health Laboratory Service (NHLS) acknowledges the concerns raised regarding delays in Anatomical Pathology services and wishes to provide clarity on the situation as well as the steps being taken to address [...]

Mashilo Masekoa2025-08-19T11:39:19+02:00

NHLS Intensifies Push to Halve Toxicology Backlog by 2025/26

Mashilo Masekoa2025-08-19T11:39:19+02:00August 19th, 2025|

NHLS Intensifies Push to Halve Toxicology Backlog by 2025/26 The National Health Laboratory Service (NHLS) is implementing a targeted strategic initiative aimed at achieving a 50% reduction in toxicology case backlog by the conclusion of [...]

Mashilo Masekoa2025-01-31T14:18:02+02:00

NHLS Monitoring Impact of U.S. Funding Freeze on HIV Testing and Research

Mashilo Masekoa2025-01-31T14:18:02+02:00January 31st, 2025|

Johannesburg, Friday, 31 January 2025 The National Health Laboratory Service (NHLS) expresses concern about the recent decision by the United States to suspend funding for HIV/AIDS initiatives. In response to the recent funding freeze, the [...]

12Next

REPORT FRAUD & CORRUPTION

Toll Free Number: 0800 000 552

SMS : 30916 (rates @ R1.50)
Email : nhls@thehotline.co.za
Free Fax : 086 726 1681

QUICK LINKS

National Biobank
SAVP
NICD
NIOH

SOCIAL MEDIA

NHLS

NICD

NIOH

PathReD

HEAD OFFICE

1 Modderfontein Road, Sandringham
Johannesburg, South Africa

Tel: 011-386-6000
Email: enquiries@nhls.ac.za
©2023 NHLS. All Rights Reserved. | Disclaimer | Terms of Use
Page load link
Go to Top